- FDA approves new injector pen for Merck KGaA fertility drug
- EMD Serono releases redesigned injector pen for infertility
- Merck KGaA, National MS Society distribute $1.3 million for early-stage drug research
- Amneal introduces generics for HIV, potassium deficiency, other conditions
- Three new Takeda diabetes drugs become available
BRIDGEWATER, N.J. — Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.
Amneal announced the changes to its metformin hydrochloride immediate-release tablets in the 500-mg, 850-mg and 1,000-mg strengths, designed to cover up the smell of metformin.
The company said the blackberry-flavored metformin, manufactured at its Brookhaven, N.Y., factory, will begin shipping this month with new national drug code numbers. The drug is a generic version of Glucophage, made by Merck Sante S.A.S., a subsidiary of Germany-based Merck KGaA, a separate and distinct company from U.S.-based Merck that operates under the name EMD Serono in the United States.